Searchable abstracts of presentations at key conferences in endocrinology

ea0051p029 | Miscellaneous/other | BSPED2017

Bisphosphonate therapy in Williams-Beuren syndrome: case series

Maduemem Kene , Kennedy Elaine , Morrissey Rose , Riordan Michael , O'Riordan Stephen M P

Introduction: Hypercalcaemia in Williams-Beuren syndrome (WBS) is usually mild and transient, but may be severe in about 5% of new presentations. Often some children will not respond well to traditional therapies.Case report: We describe three cases of acute hypercalcaemia and their management in a regional Paediatric unit. Case 1: A 16-month-old known WBS girl, presented with irritability, reduced feeding. Corrected serum calcium was 4.51 mmol/l. She wa...

ea0085oc10.4 | Oral Communications 10 | BSPED2022

Increasing patient adherence and reducing drug wastage: impact of a personalised patient support programme integrated with a digital connect ecosystem

Marie Larkin Anne , Morrissey Rose , Kaur Gurpreet , Morgan Kate , Rita Batista Ana

Background: For chronic non–life-threatening conditions such as growth hormone deficiency, adherence to treatment can be difficult to maintain at a high level especially when the benefits are not immediately apparent.1 Here, we briefly explore some of the components within an e-health ecosystem that aims at personalizing treatment and improving adherence among patients receiving recombinant human growth hormone (r hGH; somatropin, Merck Healthcare KGaA, Darmsta...